{"transactions":[{"id":723078,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34555,"kind":"person","name":"Zhang Ping","position":1,"cik":"0002050176","reported_name":"Zhang Ping","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T22:17:31.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 10, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.95,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-26-027004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126027004/form4.xml","form_type":"4"}},{"id":770397,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34555,"kind":"person","name":"Zhang Ping","position":1,"cik":"0002050176","reported_name":"Zhang Ping","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-21T01:03:16.000Z","date":"2026-05-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option was canceled by mutual agreement of the Reporting Person and the Issuer. The Issuer shall provide the Reporting Person with consideration for the cancellation of the option, the form and amount of which shall be determined by the Issuer in its sole discretion; provided that such consideration shall not be economic in value."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was canceled by mutual agreement of the Reporting Person and the Issuer. The Issuer shall provide the Reporting Person with consideration for the cancellation of the option, the form and amount of which shall be determined by the Issuer in its sole discretion; provided that such consideration shall not be economic in value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled option represented a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which would have vested on May 27, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.18,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-26-022303","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022303/form4.xml","form_type":"4"}},{"id":942536,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34555,"kind":"person","name":"Zhang Ping","position":1,"cik":"0002050176","reported_name":"Zhang Ping","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T21:01:22.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 100,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":7.31,"expiration_date":"2036-01-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-26-000832","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126000832/form4.xml","form_type":"4"}},{"id":1072532,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34555,"kind":"person","name":"Zhang Ping","position":1,"cik":"0002050176","reported_name":"Zhang Ping","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-08T00:00:41.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on August 5, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":250000,"derivative":{"exercise_price":6.92,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-25-029693","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125029693/form4.xml","form_type":"4"}},{"id":1132321,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34555,"kind":"person","name":"Zhang Ping","position":1,"cik":"0002050176","reported_name":"Zhang Ping","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-28T22:13:58.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 250,000 shares of the Issuer's common stock, 25% of which will vest on May 27, 2026, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":250000,"derivative":{"exercise_price":10.18,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-25-020669","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125020669/form4.xml","form_type":"4"}},{"id":1308528,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34555,"kind":"person","name":"Zhang Ping","position":1,"cik":"0002050176","reported_name":"Zhang Ping","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T21:05:41.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 52,000 shares of the Issuer's common stock, which will vest in 36 equal monthly installments through January 5, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":52000,"derivative":{"exercise_price":10.79,"expiration_date":"2035-01-05","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001140361-25-000426","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125000426/form4.xml","form_type":"4"}}]}